Larimar Therapeutics Ownership | Who Owns Larimar Therapeutics?


OverviewForecastFinancialsChartTranscripts

Larimar Therapeutics Ownership Summary


Larimar Therapeutics is owned by 12.55% institutional investors, 1.10% insiders, and 86.36% retail investors. Deerfield management company, l.p. (series c) is the largest institutional shareholder, holding 48.81% of LRMR shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.25% of its assets in Larimar Therapeutics shares.

LRMR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockLarimar Therapeutics12.55%1.10%86.36%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Deerfield management company, l.p. (series c)35.61M48.81%$160.23M
Blue owl capital lp7.12M9.76%$32.04M
Ra capital management6.05M9.44%$19.53M
Blackrock3.13M5.85%$22.72M
Opaleye management3.72M5.81%$10.56M
Blackrock funding, inc. /de3.75M5.14%$16.88M
Millennium management3.63M4.97%$16.31M
Aigh capital management3.00M4.11%$13.50M
Driehaus capital management2.93M4.02%$13.20M
Vanguard group3.05M3.89%$11.61M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Blue owl capital lp7.12M8.61%$32.04M
Gem investment advisors854.23K3.78%$3.84M
Dafna capital management2.03M2.08%$9.13M
Deerfield management company, l.p. (series c)35.61M1.89%$160.23M
Aigh capital management3.00M1.84%$13.50M
Opaleye management3.72M1.49%$10.56M
Altium capital management lp505.00K0.55%$1.95M
Ra capital management6.05M0.24%$19.53M
Soleus capital management1.07M0.19%$4.80M
Sphera funds management260.38K0.18%$841.04K

Top Buyers

HolderShares% AssetsChange
Deerfield management company, l.p. (series c)35.61M1.89%5.00M
Driehaus capital management2.93M0.10%2.40M
Deep track capital, lp1.50M0.11%1.50M
Dafna capital management2.03M2.08%1.09M
Soleus capital management1.07M0.19%1.07M

Top Sellers

HolderShares% AssetsChange
Janus henderson group---5.57M
Rtw investments, lp1.50M0.07%-1.63M
Millennium management3.63M0.01%-1.58M
Two sigma advisers, lp252.37K0.00%-894.55K
Citadel advisors519.13K0.00%-847.62K

New Positions

HolderShares% AssetsChangeValue
Deep track capital, lp1.50M0.11%1.50M$6.75M
Soleus capital management1.07M0.19%1.07M$4.80M
Marshall wace, llp933.46K0.00%933.46K$4.20M
Qube research847.64K0.00%847.64K$3.81M
Summittx capital379.76K0.05%379.76K$1.71M

Sold Out

HolderChange
National bank of canada /fi/-2.00
Larson financial group-4.00
Nelson, van denburg & campbell wealth management group-5.00
Capital performance advisors llp-18.00
Lindbrook capital-60.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202658-57.35%9,152,782-87.36%120.15%35-45.31%13-70.45%
Dec 31, 202591-40.91%24,571,182-71.27%310.18%39-58.06%3114.81%
Sep 30, 202514724.58%83,602,86738.89%1301.47%8722.54%2623.81%
Jun 30, 202512418.10%62,303,7192.43%971.08%7250.00%24-22.58%
Mar 31, 202510-91.80%31,178,885-50.84%480.49%5-92.19%1-97.14%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv2.34M2.25%-
Vanguard US Total Market Shares ETF1.34M2.10%-
iShares Russell 2000 ETF1.13M1.09%9.54K
Heptagon Driehaus US Micro Cap Eq C$ Acc870.10K0.84%17.53K
Fidelity Advisor Biotechnology I524.80K0.82%-
Invesco Dorsey Wright SmallCap Momt ETF422.53K0.66%-
Alger Small Cap Growth B398.96K0.62%-
iShares Russell 2000 Growth ETF388.03K0.61%-
CREF Total Global Stock Account R3569.10K0.55%569.10K
Janus Henderson Hrzn Biotec E2 USD347.56K0.54%-107.54K

Recent Insider Transactions


DateNameRoleActivityValue
Feb 27, 2026Flynn James E * Director by DeputizationBuy$4.16M
Feb 27, 2026Flynn James E * Director by DeputizationBuy$10.00M
Feb 27, 2026Flynn James E * Director by DeputizationBuy$5.42M
Feb 27, 2026Flynn James E * Director by DeputizationBuy$5.42M
Feb 27, 2026Hamilton Thomas Edward-Buy$500.00K

Insider Transactions Trends


DateBuySell
2026 Q2--
2026 Q17-
2025 Q33-
2025 Q2--
2025 Q1--

LRMR Ownership FAQ


Who Owns Larimar Therapeutics?

Larimar Therapeutics shareholders are primarily institutional investors at 12.55%, followed by 1.10% insiders and 86.35% retail investors. The average institutional ownership in Larimar Therapeutics's industry, Biotech Stocks , is 35.75%, which Larimar Therapeutics falls below.

Who owns the most shares of Larimar Therapeutics?

Larimar Therapeutics’s largest shareholders are Deerfield management company, l.p. (series c) (35.61M shares, 48.81%), Blue owl capital lp (7.12M shares, 9.76%), and Ra capital management (6.05M shares, 9.44%). Together, they hold 68.01% of Larimar Therapeutics’s total shares outstanding.

Does Blackrock own Larimar Therapeutics?

Yes, BlackRock owns 5.85% of Larimar Therapeutics, totaling 3.13M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 22.72M$. In the last quarter, BlackRock increased its holdings by 795.19K shares, a 34.00% change.

Who is Larimar Therapeutics’s biggest shareholder by percentage of total assets invested?

Blue owl capital lp is Larimar Therapeutics’s biggest shareholder by percentage of total assets invested, with 8.61% of its assets in 7.12M Larimar Therapeutics shares, valued at 32.04M$.

Who is the top mutual fund holder of Larimar Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Larimar Therapeutics shares, with 2.25% of its total shares outstanding invested in 2.34M Larimar Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools